Atricure to announce fourth quarter and full year 2015 financial
results
West chester, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in treatments for atrial fibrillation (afib) and left atrial appendage management, will release its financial results for the fourth quarter and full year 2015 on tuesday, february 23, 2016. atricure will host a conference call at 4:30 p.m. eastern time on tuesday, february 23, 2016 to discuss its fourth quarter and full year 2015 financial results. a live webcast of the conference call will be available online on the investor page of atricure’s corporate website at www.atricure.com. you may also access this call through an operator by calling (855) 307-9214 for domestic callers and (330) 863-3275 for international callers using conference id number 42156030. the webcast will be available on atricure’s website and a telephonic replay of the call will be available through march 1, 2016. the replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. the conference id number is 42156030. about atricure, inc. atricure, inc. is a medical device company providing innovative atrial fibrillation (afib) solutions designed to produce superior outcomes that reduce the economic and social burden of atrial fibrillation. atricure’s synergy™ ablation system is the first and only surgical device approved for the treatment of persistent and longstanding persistent forms of afib in patients undergoing certain open concomitant procedures. atricure’s atriclip™ left atrial appendage management (laam) exclusion device is the most widely sold device worldwide that’s indicated for the occlusion of the left atrial appendage. the company believes cardiothoracic surgeons are adopting its ablation and laam devices for the treatment of afib and reduction of afib related complications such as stroke. atricure recently acquired ncontact, a leader in minimally invasive technology for epicardial ablation. ncontact’s mission is to transform the underserved arrhythmia population through a multidisciplinary epicardial-endocardial ablation approach. afib affects more than 33 million people worldwide. for more information visit atricure.com or follow us on twitter @atricure.
ATRC Ratings Summary
ATRC Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission